A breast cancer "wonder drug" that could benefit thousands of women has been licensed for use in Britain. The drug, called Lapatinib, was praised by Jane Tomlinson's husband after the cancer campaigner received it as part of a clinical trial. After her death, Mike Tomlinson called for the drug, to be made widely available to breast cancer sufferers.
Lapatinib could be as successful as Herceptin the gold-standard treatment for breast cancer. It can prolong the lives of women in advanced stages of a type of breast cancer which accounts for around a quarter of all cases. Also known as Tyverb, the drug has received its European licence, making it available on private prescription in Britain. (Link)
Lapatinib could be as successful as Herceptin the gold-standard treatment for breast cancer. It can prolong the lives of women in advanced stages of a type of breast cancer which accounts for around a quarter of all cases. Also known as Tyverb, the drug has received its European licence, making it available on private prescription in Britain. (Link)
No comments:
Post a Comment